+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biologics & Biosimilars CXO Services Market - Global Forecast 2026-2032- Product Image
Biologics & Biosimilars CXO Services Market - Global Forecast 2026-2032- Product Image
New

Biologics & Biosimilars CXO Services Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 187 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 6079859
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Biologics & Biosimilars CXO Services Market is undergoing significant transformation as enterprises adapt strategies to address the growing complexity of science, supply, regulation, and market access. Senior leaders should anticipate sharper operational demands as biologics and biosimilars move to the core of pharma value delivery.

Market Snapshot: Biologics & Biosimilars CXO Services

In 2025, the Biologics & Biosimilars CXO Services Market was valued at USD 884.37 million, increasing to USD 957.65 million in 2026 and projected to register a CAGR of 6.94% to reach USD 1.41 billion by 2032. The industry’s shifting landscape emphasizes integration across R&D, CMC, quality systems, and supply chain as new therapeutic categories, broader adoption, and evolving policies place added pressure on end-to-end delivery.

Scope & Segmentation

  • Product Types: Monoclonal antibodies; recombinant proteins; vaccines; cell and gene therapies; advanced biologics; biosimilars.
  • Applications: Oncology; immunology; endocrinology; rare diseases; chronic care; specialty indications.
  • Route of Administration: Intravenous formulations; subcutaneous therapies; device-driven products; patient self-administration solutions.
  • End Users & Channels: Hospital systems; group purchasing organizations; specialty pharmacies; retail networks.
  • Geographic Regions: Americas; Europe; Middle East and Africa; Asia-Pacific.
  • Technology Utilization: Advanced analytics; digital quality systems; automation; serialization and traceability solutions.
{{SEGMENTATION_LIST}}

Key Takeaways for Senior Decision-Makers

  • Enterprise strategies now require unifying science, regulatory, supply, and market access disciplines into a single operating agenda.
  • Execution excellence in evidence generation, supply reliability, and contracting sophistication is setting the pace for competitive advantage.
  • Manufacturing is increasingly oriented toward resilience, with shifts toward diversified suppliers, alternative materials, and digital tools that support reliability at scale.
  • Segmentation strategies must adapt to category complexity, care settings, and stakeholder expectations—particularly in biosimilars, where switching confidence and provider engagement are pivotal.
  • Regional differences in regulatory timelines, cold-chain infrastructure, tendering structures, and health policy demand operational models capable of local adaptation without compromising quality.
  • Integrated governance—from R&D to CMC and through commercialization—reduces supply disruption risk and enables faster, more credible responses to policy and market shifts.

Tariff Impact on the Biologics & Biosimilars CXO Services Market

United States tariffs enacted in 2025 are introducing ongoing operational and financial pressures. For biologics and biosimilars, tariffs amplify variability in input costs and lead times, challenge supplier strategies, and necessitate enhanced resilience planning. Organizations are adapting with more robust supplier qualification, regionalized manufacturing footprints, and greater reliance on multi-region networks to offset future trade volatility, while recognizing that switching suppliers or materials increases change-control complexity and regulatory workloads. Balancing resilience with working capital and sustainability goals has become a critical CXO concern.

Methodology & Data Sources

This report applies rigorous secondary research across regulatory, policy, corporate, and government sources, complemented by primary interviews with industry leaders across R&D, manufacturing, regulatory, and market access. Data triangulation is used to validate themes and ensure actionable, executive-focused analysis of biologics and biosimilars market dynamics.

Why This Report Matters

  • Enables senior leaders to anticipate strategic and operational shifts across the biologics and biosimilars landscape.
  • Supports risk mitigation in light of policy, trade, and regional supply chain pressures.
  • Guides actionable planning by connecting segmentation, regional, and competitive insights to enterprise-level decision frameworks.
{{GEOGRAPHY_REGION_LIST}}

Conclusion

Integrating scientific, operational, and commercial priorities positions organizations to perform consistently despite growing market volatility and policy changes. Senior decision-makers who prioritize lifecycle governance, resilient supply, and trusted stakeholder engagement will be best placed for continued success in the evolving biologics and biosimilars sector.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Biologics & Biosimilars CXO Services Market, by Service Type
8.1. Commercialization Services
8.1.1. Launch Planning
8.1.2. Marketing
8.1.3. Medical Affairs
8.2. Digital Transformation Services
8.2.1. AI Analytics
8.2.2. Cloud Integration
8.2.3. Digital Twin Development
8.3. Manufacturing Services
8.3.1. Contract Manufacturing
8.3.2. Process Development
8.3.3. Scale-Up
8.3.4. Technology Transfer
8.4. Pharmacovigilance Services
8.4.1. Case Processing
8.4.2. Risk Management
8.4.3. Signal Detection
8.5. R&D Services
8.5.1. Biomarker Development
8.5.2. Clinical Trial Management
8.5.3. Preclinical Studies
8.6. Regulatory Services
8.6.1. Bla/Nda Support
8.6.2. Ind Submissions
8.6.3. Post-Market Surveillance
8.7. Strategy Consulting Services
8.7.1. Business Strategy Development
8.7.2. Market Assessment
8.7.3. Portfolio Optimization
8.8. Supply Chain Services
8.8.1. Cold Chain Management
8.8.2. Logistics Optimization
8.8.3. Warehouse Management
9. Biologics & Biosimilars CXO Services Market, by Therapeutic Area
9.1. Cardiovascular
9.1.1. Atherosclerosis
9.1.2. Heart Failure
9.2. Endocrinology
9.2.1. Diabetes
9.2.2. Hormonal Disorders
9.3. Immunology
9.3.1. Autoimmune Disorders
9.3.2. Inflammatory Disorders
9.4. Neurology
9.4.1. CNS Disorders
9.4.2. Neurodegenerative Diseases
9.5. Oncology
9.5.1. Hematologic Malignancies
9.5.2. Solid Tumors
9.6. Rare Diseases
9.6.1. Genetic Disorders
9.6.2. Orphan Conditions
10. Biologics & Biosimilars CXO Services Market, by Deployment Model
10.1. Cloud
10.2. Hybrid
10.3. On-Premises
11. Biologics & Biosimilars CXO Services Market, by Engagement Model
11.1. Outcome-Based
11.1.1. Performance-Based Contracts
11.1.2. Risk-Sharing Agreements
11.2. Project-Based
11.2.1. Fixed Price Projects
11.2.2. Time & Material Projects
11.3. Subscription-Based
11.3.1. Annual Subscription
11.3.2. Monthly Subscription
12. Biologics & Biosimilars CXO Services Market, by End User
12.1. Academic & Research Institutes
12.1.1. Research Hospitals
12.1.2. Universities
12.2. Biotech Firms
12.2.1. Large Biotech
12.2.2. Small & Medium Biotech
12.3. Contract Research Organizations
12.3.1. Full-Service CROs
12.3.2. Niche CROs
12.4. Pharmaceutical Companies
12.4.1. Large Pharma
12.4.2. Mid-Sized Pharma
13. Biologics & Biosimilars CXO Services Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Biologics & Biosimilars CXO Services Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Biologics & Biosimilars CXO Services Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Biologics & Biosimilars CXO Services Market
17. China Biologics & Biosimilars CXO Services Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AGC Biologics
18.6. Alvotech hf.
18.7. BioVectra Inc.
18.8. Boehringer Ingelheim International GmbH
18.9. Catalent, Inc.
18.10. Charles River Laboratories International, Inc.
18.11. Curia Global, Inc.
18.12. Excellence Through Quality GmbH
18.13. FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
18.14. Hikma Pharmaceuticals PLC
18.15. Lonza Group AG
18.16. Novasep Holding SAS
18.17. Piramal Pharma Solutions
18.18. Polpharma Biologics
18.19. PTC Bio, Inc.
18.20. Recipharm AB
18.21. Richter-Helm Biologics GmbH & Co. KG
18.22. Samsung BioLogics Co., Ltd.
18.23. Sartorius AG
18.24. Siegfried Holding AG
18.25. Thermo Fisher Scientific, Inc.
18.26. Vetter Pharma International GmbH
18.27. WuXi Biologics (Cayman) Inc.
18.28. Xellia Pharmaceuticals A/S
List of Figures
FIGURE 1. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DEPLOYMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENGAGEMENT MODEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COMMERCIALIZATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COMMERCIALIZATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COMMERCIALIZATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COMMERCIALIZATION SERVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LAUNCH PLANNING, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LAUNCH PLANNING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LAUNCH PLANNING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MARKETING, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MARKETING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MARKETING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MEDICAL AFFAIRS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MEDICAL AFFAIRS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MEDICAL AFFAIRS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TRANSFORMATION SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TRANSFORMATION SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TRANSFORMATION SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TRANSFORMATION SERVICES, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY AI ANALYTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY AI ANALYTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY AI ANALYTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLOUD INTEGRATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLOUD INTEGRATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLOUD INTEGRATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TWIN DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TWIN DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TWIN DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT MANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT MANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROCESS DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SCALE-UP, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SCALE-UP, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SCALE-UP, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY TECHNOLOGY TRANSFER, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY TECHNOLOGY TRANSFER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY TECHNOLOGY TRANSFER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE SERVICES, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CASE PROCESSING, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CASE PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CASE PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RISK MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RISK MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RISK MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SIGNAL DETECTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SIGNAL DETECTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SIGNAL DETECTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY R&D SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY R&D SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY R&D SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY R&D SERVICES, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOMARKER DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOMARKER DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOMARKER DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLINICAL TRIAL MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PRECLINICAL STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PRECLINICAL STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PRECLINICAL STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGULATORY SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGULATORY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGULATORY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGULATORY SERVICES, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BLA/NDA SUPPORT, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BLA/NDA SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BLA/NDA SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IND SUBMISSIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IND SUBMISSIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IND SUBMISSIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY POST-MARKET SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY POST-MARKET SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY POST-MARKET SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY STRATEGY CONSULTING SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY STRATEGY CONSULTING SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY STRATEGY CONSULTING SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY STRATEGY CONSULTING SERVICES, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BUSINESS STRATEGY DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BUSINESS STRATEGY DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 90. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BUSINESS STRATEGY DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 91. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MARKET ASSESSMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 92. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MARKET ASSESSMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 93. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MARKET ASSESSMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PORTFOLIO OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 95. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PORTFOLIO OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 96. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PORTFOLIO OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 97. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUPPLY CHAIN SERVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 98. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUPPLY CHAIN SERVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 99. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUPPLY CHAIN SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 100. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUPPLY CHAIN SERVICES, 2018-2032 (USD MILLION)
TABLE 101. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COLD CHAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 102. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COLD CHAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 103. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COLD CHAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 104. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LOGISTICS OPTIMIZATION, BY REGION, 2018-2032 (USD MILLION)
TABLE 105. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LOGISTICS OPTIMIZATION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 106. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LOGISTICS OPTIMIZATION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 107. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY WAREHOUSE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 108. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY WAREHOUSE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 109. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY WAREHOUSE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 110. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 111. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2032 (USD MILLION)
TABLE 112. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY GROUP, 2018-2032 (USD MILLION)
TABLE 113. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CARDIOVASCULAR, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 114. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2018-2032 (USD MILLION)
TABLE 115. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 116. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 117. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ATHEROSCLEROSIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HEART FAILURE, BY REGION, 2018-2032 (USD MILLION)
TABLE 119. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HEART FAILURE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 120. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HEART FAILURE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 121. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENDOCRINOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 122. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENDOCRINOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 123. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENDOCRINOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 124. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENDOCRINOLOGY, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIABETES, BY REGION, 2018-2032 (USD MILLION)
TABLE 126. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIABETES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 127. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 128. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 129. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HORMONAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 130. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HORMONAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 131. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 132. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IMMUNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 133. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IMMUNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY IMMUNOLOGY, 2018-2032 (USD MILLION)
TABLE 135. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 136. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 137. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 138. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY INFLAMMATORY DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 139. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY INFLAMMATORY DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 140. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY INFLAMMATORY DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 142. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEUROLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 143. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEUROLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEUROLOGY, 2018-2032 (USD MILLION)
TABLE 145. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CNS DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 146. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CNS DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 147. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CNS DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
TABLE 152. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 153. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 154. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2032 (USD MILLION)
TABLE 155. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 156. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 157. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HEMATOLOGIC MALIGNANCIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 158. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SOLID TUMORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 159. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SOLID TUMORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 160. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SOLID TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RARE DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 162. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RARE DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 163. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RARE DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 164. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RARE DISEASES, 2018-2032 (USD MILLION)
TABLE 165. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 166. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 167. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ORPHAN CONDITIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 169. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ORPHAN CONDITIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 170. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ORPHAN CONDITIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 171. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DEPLOYMENT MODEL, 2018-2032 (USD MILLION)
TABLE 172. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
TABLE 173. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
TABLE 174. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HYBRID, BY REGION, 2018-2032 (USD MILLION)
TABLE 176. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HYBRID, BY GROUP, 2018-2032 (USD MILLION)
TABLE 177. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY HYBRID, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 178. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ON-PREMISES, BY REGION, 2018-2032 (USD MILLION)
TABLE 179. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ON-PREMISES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 180. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ON-PREMISES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ENGAGEMENT MODEL, 2018-2032 (USD MILLION)
TABLE 182. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY OUTCOME-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 183. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY OUTCOME-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 184. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY OUTCOME-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 185. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY OUTCOME-BASED, 2018-2032 (USD MILLION)
TABLE 186. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PERFORMANCE-BASED CONTRACTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 187. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PERFORMANCE-BASED CONTRACTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 188. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PERFORMANCE-BASED CONTRACTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 189. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RISK-SHARING AGREEMENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 190. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RISK-SHARING AGREEMENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 191. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RISK-SHARING AGREEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 192. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROJECT-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 193. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROJECT-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 194. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROJECT-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 195. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PROJECT-BASED, 2018-2032 (USD MILLION)
TABLE 196. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY FIXED PRICE PROJECTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 197. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY FIXED PRICE PROJECTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY FIXED PRICE PROJECTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY TIME & MATERIAL PROJECTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 200. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY TIME & MATERIAL PROJECTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 201. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY TIME & MATERIAL PROJECTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 202. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, BY REGION, 2018-2032 (USD MILLION)
TABLE 203. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, BY GROUP, 2018-2032 (USD MILLION)
TABLE 204. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 205. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUBSCRIPTION-BASED, 2018-2032 (USD MILLION)
TABLE 206. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ANNUAL SUBSCRIPTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 207. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ANNUAL SUBSCRIPTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 208. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ANNUAL SUBSCRIPTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 209. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MONTHLY SUBSCRIPTION, BY REGION, 2018-2032 (USD MILLION)
TABLE 210. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MONTHLY SUBSCRIPTION, BY GROUP, 2018-2032 (USD MILLION)
TABLE 211. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MONTHLY SUBSCRIPTION, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 212. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 213. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
TABLE 214. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 215. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, 2018-2032 (USD MILLION)
TABLE 217. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RESEARCH HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 218. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RESEARCH HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 219. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY RESEARCH HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 220. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY UNIVERSITIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 221. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY UNIVERSITIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 222. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY UNIVERSITIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 223. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOTECH FIRMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 224. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOTECH FIRMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 225. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOTECH FIRMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 226. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY BIOTECH FIRMS, 2018-2032 (USD MILLION)
TABLE 227. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LARGE BIOTECH, BY REGION, 2018-2032 (USD MILLION)
TABLE 228. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LARGE BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 229. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LARGE BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 230. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SMALL & MEDIUM BIOTECH, BY REGION, 2018-2032 (USD MILLION)
TABLE 231. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SMALL & MEDIUM BIOTECH, BY GROUP, 2018-2032 (USD MILLION)
TABLE 232. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SMALL & MEDIUM BIOTECH, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 233. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 234. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 235. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 236. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, 2018-2032 (USD MILLION)
TABLE 237. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY FULL-SERVICE CROS, BY REGION, 2018-2032 (USD MILLION)
TABLE 238. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY FULL-SERVICE CROS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 239. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY FULL-SERVICE CROS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 240. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NICHE CROS, BY REGION, 2018-2032 (USD MILLION)
TABLE 241. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NICHE CROS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 242. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY NICHE CROS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 243. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 244. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 245. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 246. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACEUTICAL COMPANIES, 2018-2032 (USD MILLION)
TABLE 247. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LARGE PHARMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 248. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LARGE PHARMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 249. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY LARGE PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 250. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MID-SIZED PHARMA, BY REGION, 2018-2032 (USD MILLION)
TABLE 251. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MID-SIZED PHARMA, BY GROUP, 2018-2032 (USD MILLION)
TABLE 252. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MID-SIZED PHARMA, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 253. GLOBAL BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 254. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 255. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
TABLE 256. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY COMMERCIALIZATION SERVICES, 2018-2032 (USD MILLION)
TABLE 257. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY DIGITAL TRANSFORMATION SERVICES, 2018-2032 (USD MILLION)
TABLE 258. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY MANUFACTURING SERVICES, 2018-2032 (USD MILLION)
TABLE 259. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY PHARMACOVIGILANCE SERVICES, 2018-2032 (USD MILLION)
TABLE 260. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY R&D SERVICES, 2018-2032 (USD MILLION)
TABLE 261. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY REGULATORY SERVICES, 2018-2032 (USD MILLION)
TABLE 262. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY STRATEGY CONSULTING SERVICES, 2018-2032 (USD MILLION)
TABLE 263. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY SUPPLY CHAIN SERVICES, 2018-2032 (USD MILLION)
TABLE 264. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY THERAPEUTIC AREA, 2018-2032 (USD MILLION)
TABLE 265. AMERICAS BIOLOGICS & BIOSIMILARS CXO SERVICES MARKET SIZE, BY CARDIOVASCULAR, 2018

Companies Mentioned

The key companies profiled in this Biologics & Biosimilars CXO Services market report include:
  • AGC Biologics
  • Alvotech hf.
  • BioVectra Inc.
  • Boehringer Ingelheim International GmbH
  • Catalent, Inc.
  • Charles River Laboratories International, Inc.
  • Curia Global, Inc.
  • Excellence Through Quality GmbH
  • FUJIFILM Diosynth Biotechnologies U.S.A., Inc.
  • Hikma Pharmaceuticals PLC
  • Lonza Group AG
  • Novasep Holding SAS
  • Piramal Pharma Solutions
  • Polpharma Biologics
  • PTC Bio, Inc.
  • Recipharm AB
  • Richter‑Helm Biologics GmbH & Co. KG
  • Samsung BioLogics Co., Ltd.
  • Sartorius AG
  • Siegfried Holding AG
  • Thermo Fisher Scientific, Inc.
  • Vetter Pharma International GmbH
  • WuXi Biologics (Cayman) Inc.
  • Xellia Pharmaceuticals A/S

Table Information

Report AttributeDetails
No. of Pages187
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 957.65 Million
Forecasted Market Value ( USD ) by 2032 $ 1410 Million
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Psoriasis Biosimilar Market - Global Forecast 2026-2032 - Product Image

Psoriasis Biosimilar Market - Global Forecast 2026-2032

  • Report
  • 185 Pages
  • Global
From
Biosimilars Market - Global Forecast 2026-2032 - Product Image

Biosimilars Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035 - Product Image

Biosimilars Market by Drug Class (mAbs (Adalimumab, Infliximab, Rituximab, Trastuzumab), GCSF, Insulin, Anticoagulant, rhGH, Teriparatide, GLP-1), Indication (Oncology, Autoimmune, Diabetes, Obesity), Competitive Landscape, Region - Global Forecast to 2035

  • Report
  • 392 Pages
  • Global
From
Biosimilars Market Overview, 2025-30 - Product Image

Biosimilars Market Overview, 2025-30

  • Report
  • 102 Pages
  • Global
From
Biosimilar Contract Manufacturing Market Size, Share & Trends Analysis Report by Source (Mammalian, Non-mammalian), Therapeutic Area (Oncology, Blood Disorders), Service, and Region with Growth Forecasts, 2025-2033 - Product Image

Biosimilar Contract Manufacturing Market Size, Share & Trends Analysis Report by Source (Mammalian, Non-mammalian), Therapeutic Area (Oncology, Blood Disorders), Service, and Region with Growth Forecasts, 2025-2033

  • Report
  • 180 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.